US14843C1053
US14843C1053
Castle Biosciences, Inc.
Loading chart...
Financials
Updating data...
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Updating data...
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 344.229.000 | 332.069.000 | 3.7% |
| Cost of Revenue | 71.028.000 | 60.205.000 | 18.0% |
| Gross Profit | 273.201.000 | 271.864.000 | 0.5% |
| 316.011.000 | 263.194.000 | 20.1% | |
| Operating Income | -42.810.000 | 8.670.000 | 593.8% |
| Pretax Income | -29.514.000 | 21.564.000 | 236.9% |
| Net Income Common Stockholders | -24.158.000 | 18.245.000 | 232.4% |
| -- | -- | -- | |
| -- | -- | -- |